Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323

NCT00484536 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

232

Enrollment

INDUSTRY

Sponsor class

Stopped The study was discontinued due to unfavorable interim analysis

Conditions

Multiple Sclerosis

Interventions

DRUG: CDP323
DRUG: placebo
DRUG: CDP323

Sponsor

UCB Pharma

Collaborators

[object Object]